Saturday 17 October 2026
Export ANGO’s income statement to Excel — free account
AngioDynamics, Inc.
ANGO Healthcare Medical Instruments & Supplies
AngioDynamics, Inc.’s revenue for fiscal 2026 (year ended May 2026) was $320.2 million, up 9.46% from fiscal 2025. In the quarter to August 2026, revenue grew 6.87%, EPS grew 35.0% and free cash flow grew 5.62%, each against the same quarter a year earlier.
11.25
0.33
−2.85%
Follow ANGO
| May '17 | May '18 | May '19 | May '20 | May '21 | May '22 | May '23 | May '24 | May '25 | May '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 7 | 5 | 3 | 5 | 3 | 4 | 4 | 6 | 5 |
P/E ratio |
79.37 | 47.17 | 11.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
2.16 | 3.38 | 2.65 | 1.15 | 4.52 | 3.73 | 1.40 | (1.04) | 1.40 | 1.63 |
P/S ratio |
2.05 | 2.98 | 2.60 | 1.49 | 3.09 | 2.42 | 1.10 | 0.83 | 1.35 | 1.42 |
Altman Z″-Score (non-manufacturers) |
3.41 | 4.42 | 4.99 | 2.11 | 3.57 | 3.01 | 1.62 | (4.09) | (1.82) | (2.65) |
P/FCF ratio |
11.47 | 22.69 | 23.64 | 0.00 | 48.54 | 0.00 | 0.00 | 2.53 | 0.00 | 0.00 |
Beneish M-Score |
(3.08) | (2.91) | (2.82) | (3.81) | (2.63) | (2.34) | (3.11) | (5.27) | (2.80) | (3.08) |
P/Operating CF |
29.07 | 32.80 | 28.16 | 101.56 | 73.83 | 89.46 | 23.41 | 50.70 | 21.07 | 25.96 |
P/B ratio |
1.07 | 1.44 | 1.15 | 0.87 | 2.05 | 1.80 | 0.99 | 1.23 | 2.17 | 2.65 |
Price to Tangible BV |
68.17 | 5.41 | 5.78 | 6.89 | 13.02 | 10.78 | 3.46 | 1.98 | 3.48 | 4.37 |
EV/Sales |
2.22 | 3.04 | 2.25 | 1.47 | 3.02 | 2.43 | 1.14 | 0.77 | 1.35 | 1.42 |
EV/EBITDA |
43.98 | 88.50 | 36.92 | 25.33 | 0.00 | 876.33 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
10.76 | 19.28 | 16.26 | (26.60) | 36.52 | (106.95) | 4,951.01 | (8.34) | (39.02) | 146.97 |
EV/FCF |
12.46 | 23.16 | 20.43 | (17.48) | 47.42 | (64.98) | (80.22) | 2.35 | (21.50) | (138.33) |
Quick Ratio |
1.30 | 2.00 | 3.70 | 1.67 | 1.45 | 1.09 | 1.16 | 1.31 | 1.30 | 1.37 |
Current Ratio |
2.15 | 2.93 | 4.30 | 2.97 | 2.45 | 1.93 | 1.95 | 2.12 | 2.21 | 2.19 |
Net Debt/EBITDA |
3.49 | 1.80 | (5.81) | (0.94) | 3.01 | (4.36) | (0.90) | 14.50 | 3.95 | 3.17 |
Debt/Assets |
13.61% | 12.99% | 15.77% | 6.73% | 3.56% | 4.52% | 9.35% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.19 | 0.17 | 0.21 | 0.09 | 0.05 | 0.06 | 0.13 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.38 | 0.37 | 0.35 | 0.37 | 0.50 | 0.57 | 0.62 | 0.71 | 0.98 | 1.17 |
Operating CF/Net income |
11.13 | 2.53 | 0.61 | 0.09 | (0.76) | 0.27 | 0.00 | 0.15 | 0.30 | (0.08) |
Capex/Depreciation |
(0.12) | (0.16) | (0.12) | (0.04) | (0.20) | (0.15) | (0.10) | 0.69 | (0.17) | (0.11) |
Interest Coverage |
(3.94) | (4.63) | (1.84) | (184.23) | (40.98) | (41.38) | (18.94) | 119.23 | 40.85 | (133.54) |
| 0.98% | 3.09% | 10.60% | (31.18%) | (7.06%) | (6.15%) | (13.07%) | (63.15%) | (17.50%) | (20.77%) | |
| 0.70% | 2.31% | 7.96% | (23.32%) | (5.46%) | (4.77%) | (9.66%) | (43.36%) | (11.37%) | (13.43%) | |
ROIC |
(1.24%) | (1.58%) | (1.13%) | (23.71%) | (5.36%) | (4.23%) | (8.34%) | (92.85%) | (19.65%) | (21.34%) |
Return on Tangible Assets |
3.92% | 11.97% | 23.04% | (128.52%) | (26.21%) | (23.28%) | (42.26%) | (133.82%) | (27.32%) | (31.74%) |
Average Days of Receivables |
60.24 | 54.96 | 58.77 | 43.20 | 44.41 | 60.37 | 56.92 | 52.38 | 53.52 | 55.09 |
Research and Development Expense of Revenue |
8.95% | 9.30% | 10.44% | 11.24% | 12.50% | 9.72% | 8.82% | 10.37% | 8.96% | 9.20% |
Selling, General and Administrative Expense of Revenue |
39.29% | 39.79% | 41.28% | 44.10% | 40.28% | 42.30% | 42.58% | 47.38% | 49.65% | 49.06% |
Intangible Assets out of Total Assets |
0.72 | 0.56 | 0.59 | 0.67 | 0.66 | 0.64 | 0.51 | 0.24 | 0.25 | 0.25 |
Share Based Compensation of Revenue |
2.29% | 3.02% | 3.42% | 2.87% | 2.96% | 3.38% | 3.29% | 3.46% | 3.34% | 4.36% |
Graham Net Nets |
(0.07) | 0.01 | 0.13 | 0.03 | 0.02 | 0.02 | 0.02 | 0.32 | 0.18 | 0.15 |
Graham Number |
7.75 | 12.12 | 24.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
1.26% | 2.12% | 8.73% | (41.91%) | (3.49%) | (3.46%) | (13.95%) | (73.38%) | (8.56%) | (7.97%) |
Free Cash Flow Yield |
8.72% | 4.41% | 4.23% | (5.62%) | 2.06% | (1.55%) | (1.29%) | 39.45% | (4.64%) | (0.72%) |
Revenue per Share |
7.37 | 7.06 | 7.22 | 6.96 | 7.59 | 8.11 | 8.58 | 7.56 | 7.16 | 7.71 |
Operating CF per Share |
1.52 | 1.11 | 1.00 | (0.38) | 0.63 | (0.18) | 0.00 | (0.70) | (0.25) | 0.07 |
Capex per Share |
(0.08) | (0.10) | (0.08) | (0.20) | (0.14) | (0.11) | (0.11) | 3.20 | (0.11) | (0.06) |
Free Cash Flow per Share |
1.44 | 1.02 | 0.92 | (0.58) | 0.49 | (0.29) | (0.11) | 2.50 | (0.36) | 0.01 |
Cash per Share |
1.33 | 2.03 | 6.07 | 1.43 | 1.26 | 0.74 | 1.13 | 1.89 | 1.37 | 1.30 |
Shareholders Equity per Share |
14.07 | 14.64 | 16.40 | 11.98 | 11.46 | 10.88 | 9.58 | 5.12 | 4.48 | 4.11 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
14.07 | 14.64 | 16.40 | 11.98 | 11.46 | 10.88 | 9.58 | 5.12 | 4.48 | 4.11 |
Free Cash Flow |
52.74 | 37.63 | 34.32 | (22.14) | 18.91 | (11.49) | (4.27) | 100.57 | (14.59) | 0.51 |
Working Capital |
82.40 | 110.73 | 241.99 | 101.47 | 83.30 | 69.02 | 79.72 | 102.10 | 92.13 | 88.68 |
Capital Expenditures |
(3.00) | (3.66) | (3.12) | (7.58) | (5.19) | (4.30) | (4.35) | 128.73 | (4.46) | (2.58) |
Net Current Asset Value |
(39.02) | 5.16 | 93.67 | 13.57 | 18.90 | 15.08 | 9.20 | 81.17 | 71.15 | 67.06 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.03 | 0.02 | 0.01 | 0.01 | (0.42) | 0.02 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.55 | 0.90 | 1.07 | 6.44 | 0.70 | 0.65 | 1.02 | 5.25 | 0.80 | 0.85 |
Cash ROIC |
7.99% | 5.30% | 3.52% | (4.03%) | 3.72% | (2.40%) | (0.90%) | 35.71% | (6.11%) | 0.23% |
Accounts Receivable Turnover |
5.54 | 6.24 | 6.52 | 7.06 | 8.73 | 7.21 | 6.44 | 6.30 | 6.76 | 7.02 |
Accounts Payable Turnover |
7.47 | 6.96 | 5.94 | 5.43 | 6.93 | 6.31 | 4.80 | 3.82 | 3.79 | 4.48 |
Inventory Turnover |
2.29 | 2.51 | 2.89 | 2.28 | 2.47 | 3.01 | 3.08 | 2.57 | 2.20 | 2.54 |
Average Days of Payables |
52.46 | 48.88 | 72.69 | 61.20 | 53.38 | 68.03 | 89.74 | 92.34 | 90.15 | 79.17 |
Days of Inventory on Hand |
158.10 | 121.69 | 127.59 | 191.99 | 132.20 | 124.65 | 122.75 | 148.27 | 167.90 | 131.74 |
Average Receivables |
48.70 | 41.96 | 41.49 | 37.42 | 33.33 | 43.85 | 52.57 | 48.22 | 43.25 | 45.61 |
Average Payables |
16.85 | 16.93 | 19.30 | 20.96 | 19.36 | 23.84 | 34.25 | 39.10 | 35.52 | 32.40 |
Average Inventory |
54.94 | 46.89 | 39.67 | 49.99 | 54.26 | 50.00 | 53.36 | 57.97 | 61.31 | 57.22 |
Average Assets |
717.08 | 706.72 | 770.96 | 715.33 | 577.83 | 557.09 | 542.69 | 425.15 | 298.91 | 273.65 |
Average Common Equity |
511.13 | 528.81 | 578.71 | 534.84 | 447.16 | 431.97 | 401.39 | 291.94 | 194.28 | 176.90 |
Columns are period end dates · fundamentals updated 13 Oct 2026